AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,554.00p
   
  • Change Today:
      38.00p
  • 52 Week High: 12,640.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.26m
  • Volume: 115,641
  • Market Cap: £194,619m
  • RiskGrade: 123

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
78.46% above the market average78.46% above the market average78.46% above the market average78.46% above the market average78.46% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
1yr Revenue Growth
23.16% below the market average23.16% below the market average23.16% below the market average23.16% below the market average23.16% below the market average
21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
56.73% below the market average56.73% below the market average56.73% below the market average56.73% below the market average56.73% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
85.85% below the market average85.85% below the market average85.85% below the market average85.85% below the market average85.85% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
33.13% above the market average33.13% above the market average33.13% above the market average33.13% above the market average33.13% above the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Price Chg 3m
73.30% above the market average73.30% above the market average73.30% above the market average73.30% above the market average73.30% above the market average
62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
43.90% above the market average43.90% above the market average43.90% above the market average43.90% above the market average43.90% above the market average
44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average
Momentum 20
99.60% above the market average99.60% above the market average99.60% above the market average99.60% above the market average99.60% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
35.48% above the market average35.48% above the market average35.48% above the market average35.48% above the market average35.48% above the market average
88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average
ROCE
77.10% above the market average77.10% above the market average77.10% above the market average77.10% above the market average77.10% above the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
98.07% above the market average98.07% above the market average98.07% above the market average98.07% above the market average98.07% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Forecast EPS
96.98% above the market average96.98% above the market average96.98% above the market average96.98% above the market average96.98% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
98.59% above the market average98.59% above the market average98.59% above the market average98.59% above the market average98.59% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Operating Profit Loss
98.77% above the market average98.77% above the market average98.77% above the market average98.77% above the market average98.77% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
96.88% above the market average96.88% above the market average96.88% above the market average96.88% above the market average96.88% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Cash
97.49% above the market average97.49% above the market average97.49% above the market average97.49% above the market average97.49% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
48.76% above the market average48.76% above the market average48.76% above the market average48.76% above the market average48.76% above the market average
41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
11.34% above the market average11.34% above the market average11.34% above the market average11.34% above the market average11.34% above the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average
Brokers Percent Neutral
69.53% below the market average69.53% below the market average69.53% below the market average69.53% below the market average69.53% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,554.00p
Change Today 38.00p
% Change 0.30 %
52 Week High 12,640.00
52 Week Low 9,501.00
Volume 115,641
Shares Issued 1,550.26m
Market Cap £194,619m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.83% below the market average91.83% below the market average91.83% below the market average91.83% below the market average91.83% below the market average
92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average
Price Trend
64.48% above the market average64.48% above the market average64.48% above the market average64.48% above the market average64.48% above the market average
85.19% above the sector average85.19% above the sector average85.19% above the sector average85.19% above the sector average85.19% above the sector average
Income
91.68% below the market average91.68% below the market average91.68% below the market average91.68% below the market average91.68% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
82.57% above the market average82.57% above the market average82.57% above the market average82.57% above the market average82.57% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average

What The Brokers Say

Strong Buy 9
Buy 16
Neutral 5
Sell 0
Strong Sell 1
Total 31
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 06-Jun-2024

Time Volume / Share Price
08:53 193 @ 12,554.00p
08:53 52 @ 12,554.00p
08:53 17 @ 12,554.00p
08:53 33 @ 12,554.00p
08:53 33 @ 12,554.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page